Gabapentinoid Use in the United States 2002 Through 2015
Top Cited Papers
- 1 February 2018
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 178 (2), 292-294
- https://doi.org/10.1001/jamainternmed.2017.7856
Abstract
This cohort study uses 2002-2015 Medical Expenditure Panel Survey data to characterize the use of gabapentinoids among the US adult population.This publication has 5 references indexed in Scilit:
- Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control studyPLoS Medicine, 2017
- Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trialsPLoS Medicine, 2017
- Trial of Pregabalin for Acute and Chronic SciaticaNew England Journal of Medicine, 2017
- Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?CNS Drugs, 2014
- False Claims Act Prosecution Did Not Deter Off-Label Drug Use In The Case Of NeurontinHealth Affairs, 2011